Eastern Cooperative Oncology Group N Engl J Med 2000, 343:1217–1

Eastern Cooperative Oncology Group. N Engl J Med 2000, 343:1217–1222.PubMedCrossRef 17. Douillard JY: Adjuvant TPCA-1 chemotherapy for non-small-cell lung cancer: it does not always fade with time. J Clin Oncol 28:3–5. 18. Pignon JP, Tribodet H, Scagliotti

GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, et al.: Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008, 26:3552–3559.PubMedCrossRef 19. Berghmans T, Paesmans M, Meert AP, Mascaux C, Lothaire P, Lafitte JJ, Sculier JP: Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer 2005, 49:13–23.PubMedCrossRef 20. Bria E, Gralla RJ, Raftopoulos H, Cuppone F, Milella M, Sperduti I, Carlini

P, Terzoli E, Cognetti F, Giannarelli D: Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials. Lung Cancer 2009, 63:50–57.PubMedCrossRef 21. Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto KU55933 M: Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004, 22:3860–3867.PubMedCrossRef 22. Sedrakyan A, Van Der Meulen J, O’Byrne K, Prendiville J, Hill J, Treasure T: Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 2004, 128:414–419.PubMedCrossRef 23. Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, Le Verubecestat molecular weight Chevalier T, Le Pechoux C, Parmar MK, Pignon JP, Souhami RL, et al.: Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 2010, 375:1267–1277.PubMedCrossRef 24. Banna GL, Di

Maio M, Follador A, Collova E, Menis J, Novello S, Bria E, Airoldi M, Amoroso D, Ardizzoia A, et al.: Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA). Lung Cancer 73:78–88. Bcl-w 25. Booth CM, Shepherd FA, Peng Y, Darling GE, Li G, Kong W, Mackillop WJ: Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study. J Clin Oncol 28:3472–3478. 26. Cuffe S, Booth CM, Peng Y, Darling GE, Li G, Kong W, Mackillop WJ, Shepherd FA: Adoption of adjuvant chemotherapy (ACT) for non-small cell lung cancer (NSCLC) in the elderly: A population-based outcomes study. ASCO Meeting Abstracts 29:7012. 27. Gu F, Strauss GM, Wisnivesky JP: Platinum-based adjuvant chemotherapy (ACT) in elderly patients with non-small cell lung cancer (NSCLC) in the SEER-Medicare database: Comparison between carboplatin- and cisplatin-based regimens. ASCO Meeting Abstracts 29:7014. 28.

This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>